Previous close | 0.0400 |
Open | 0.0400 |
Bid | 0.0300 x 7867300 |
Ask | 0.0400 x 1875100 |
Day's range | 0.0400 - 0.0400 |
52-week range | 0.0390 - 0.0880 |
Volume | |
Avg. volume | 71,780 |
Market cap | 11.274M |
Beta (5Y monthly) | 0.19 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.0020 |
Earnings date | 15 Aug 2022 - 19 Aug 2022 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | 19 Oct 2012 |
1y target est | N/A |
Ladies and gentlemen, I am pleased to report that BTC Health Limited (ASX:BTC) has achieved a number of milestones over the past 12 months, including a greater penetration of our products within hospitals.
I am pleased to provide you with a detailed update on BTC Health Limited's (ASX:BTC) investments, along with an operational update of BTC's wholly owned investee companies.
The primary objective for BTC Speciality Health is to increase market share through organic growth. New products will continue to be sourced by BioImpact and will enable BTC Speciality Health to expand its product range within pain management and critical care.